Barnhart K F, Wojcieszyn J, Storts R W
Department of Veterinary Pathobiology, Texas A&M University, College of Veterinary Medicine, College Station 77833-4457, USA.
Vet Pathol. 2002 May;39(3):311-21. doi: 10.1354/vp.39-3-311.
This study examined immunohistochemical staining patterns for several meningioma variants involving either the brain or spinal cord of dogs. Formalin-fixed, paraffin-embedded tissue from 15 tumors was obtained. The selected tumor group included seven meningothelial, three transitional, two malignant (anaplastic), one myxoid, one papillary, and one osteomatous meningiomas. Tumors were evaluated for reactivity to the following six immunohistochemical markers: vimentin, pancytokeratin, glial fibrillary acidic protein (GFAP), S100, neuron-specific enolase (NSE), and synaptophysin. Vimentin expression was detected in all meningiomas, and 14 of 15 tumors demonstrated intense vimentin staining in more than 50% of the neoplastic cells. Pancytokeratin expression was present in 11 of 15 neoplasms; however, positive staining frequently was focal and often involved a small percentage of the neoplastic cells. GFAP expression was detected in a single, anaplastic meningioma. Although expression of NSE and S100 was detected in 12 of 25 meningiomas, the intensity of the staining and the percentage of positive neoplastic cells was highly variable. Synaptophysin was uniformly negative. These results will help to establish immunohistochemical profiles for meningiomas that will improve our ability to correctly differentiate these neoplasms of meningeal origin from central nervous system tumors originating from other sites.
本研究检测了几种累及犬脑或脊髓的脑膜瘤变体的免疫组织化学染色模式。从15个肿瘤中获取了福尔马林固定、石蜡包埋的组织。所选肿瘤组包括7个脑膜皮型、3个过渡型、2个恶性(间变性)、1个黏液型、1个乳头型和1个骨瘤型脑膜瘤。对肿瘤进行以下六种免疫组织化学标志物反应性评估:波形蛋白、全细胞角蛋白、胶质纤维酸性蛋白(GFAP)、S100、神经元特异性烯醇化酶(NSE)和突触素。所有脑膜瘤均检测到波形蛋白表达,15个肿瘤中有14个在超过50%的肿瘤细胞中表现出强烈的波形蛋白染色。15个肿瘤中有11个存在全细胞角蛋白表达;然而,阳性染色通常是局灶性的,且常累及一小部分肿瘤细胞。在单个间变性脑膜瘤中检测到GFAP表达。虽然在25个脑膜瘤中有12个检测到NSE和S100表达,但染色强度和阳性肿瘤细胞百分比差异很大。突触素均为阴性。这些结果将有助于建立脑膜瘤的免疫组织化学图谱,提高我们将这些脑膜起源的肿瘤与起源于其他部位的中枢神经系统肿瘤正确区分开来的能力。